Coherus BioSciences (CHRS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CHRS is expected to report earnings to rise 11.50% to -15 cents per share on November 04

Coherus BioSciences CHRS Stock Earnings Reports

Q3'24

Est.

$-0.16

Q2'24

Beat

by $0.11

Q1'24

Missed

by $0.07

Q4'23

Missed

by $0.41

Q3'23

Beat

by $0.11

The last earnings report on August 08 showed earnings per share of -14 cents, beating the estimate of -25 cents. With 1.25M shares outstanding, the current market capitalization sits at 120.97M.

View a ticker or compare two or three

Compare

CHRS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CHRS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a maker of biologic therapeutics for oncology and inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

333 Twin Dolphin Drive

Phone

+1 650 649-3530

Employees

306

Web

https://www.coherus.com